Videos

Resources on biosimilar medicines

Menu

11

December 2023

0

Biosimilars in thrombosis prevention: enoxaparin sodium

11 2023 December Other entities Biosim

13

November 2023

0

Biosimilars in diabetes: insulin glargine

November 13 2023 Other entities Biosim

17

Deireadh Fómhair 2023

0

Biosimilars in Oncology: What are they and what do they provide to patients?

October 17 2023 Other entities Biosim

09

Deireadh Fómhair 2023

0

Biosimilars in Crohn's and ulcerative colitis: adalimumab and infliximab

October 09 2023 Other entities Biosim

11

Sep 2023

0

Biosimilars in psoriasis: adalimumab, etanercept, infliximab

11 September 2023 Other entities Biosim

10

July 2023

0

Biosimilars in cancer: trastuzumab, bevacizumab, rituximab, epoetins, filgrastim, pegfilgrastim

Jul 10 2023 Other entities Biosim

12

Meitheamh 2023

0

Biosimilars in arthritis adalimumab, etanercept and infliximab

12 June 2023 Other entities Biosim

02

Meitheamh 2023

0

Shared gains with biosimilars

02 June 2023 biosim Biosim

12

December 2022

0

What do biosimilar medicines contribute to the National Health System?

12 2022 December Other entities Biosim

22

November 2022

0

Join the biosimilar movement

November 22 2022 biosim Biosim

17

November 2022

0

BIO what? BIOSIMILAR!

November 17 2022 biosim Biosim

14

November 2022

0

What are the main hoaxes about biosimilar medicines?

November 14 2022 biosim Biosim

07

November 2022

0

The Science Behind Biosimilars with mAbxience

November 07 2022 biosim Biosim

10

Deireadh Fómhair 2022

0

Since when have biosimilar medicines existed in Europe?

October 10 2022 Other entities Biosim

22

Sep 2022

0

22nd National Pharmaceutical Congress - Encarnación Cruz: "We have digital tools that we should optimize, such as the electronic prescription"

22 September 2022 biosim Biosim

18

Sep 2022

0

How Adalimumab is self-administered

18 September 2022 Other entities Biosim

12

Sep 2022

0

How is the quality, safety and efficacy of biosimilar medicines ensured?

12 September 2022 Other entities Biosim

04

July 2022

0

How is a biosimilar different from a generic drug?

Jul 04 2022 Other entities Biosim

13

Meitheamh 2022

0

What is a biosimilar biological medicine?

13 June 2022 Other entities Biosim

12

May 2022

0

Report Biosimilars in the New National Health System: proposals for action

12 May 2022 biosim Biosim

25

Apr 2022

0

Encarnación Cruz on OAFIRadio. Biosimilar Medicines Explained for a Wide Audience

Apr 25 2022 biosim Biosim

02

Apr 2022

0

Research and manufacturing of biosimilars in Spain must be encouraged to boost innovation and competition

Apr 02 2022 biosim Biosim

17

Márta 2022

0

From biologics to biosimilars: do you know the way?

March 17 2022 biosim Biosim

02

Márta 2022

0

Biosimilars in the new NHS: proposals for action

March 02 2022 biosim Biosim

01

Márta 2022

0

Biosimilar medicines: current situation and future vision

March 01 2022 Other entities Biosim

30

November 2021

0

BioSim presents the report "Public procurement of biosimilar medicines in the National Health System"

November 30 2021 biosim Biosim

05

November 2021

0

How to communicate around biosimilars – with Spanish subtitles

November 05 2021 Other entities Biosim

20

Apr 2021

0

Patricia Lacruz, Ministry of Health: 15th anniversary of the 1st biosimilar in Europe

Apr 20 2021 Other entities Biosim

12

Apr 2021

0

Joaquín Rodrigo, President of BioSim: 15th anniversary of the 1st biosimilar in Europe

Apr 12 2021 biosim Biosim

17

November 2020

0

What exactly is a biosimilar?

November 17 2020 Other entities Biosim

15

November 2020

0

Conference for patients "Biosimilars: quality, safety and efficiency"- Dr. Adriana Pascual

November 15 2020 biosim Biosim

15

November 2020

0

Conference for patients "Biosimilars: quality, safety and efficiency" Prof. Fernando de Mora

November 15 2020 biosim Biosim

23

July 2020

0

Biosimilars in oncology: an opportunity for the present and the future

Jul 23 2020 Other entities Biosim

03

Deireadh Fómhair 2019

0

Biosimilar medicines: an opportunity for the patient

October 03 2019 biosim Biosim

03

Deireadh Fómhair 2019

0

The Senate welcomes the presentation of the biosimilar medicines guide

October 03 2019 Other entities Biosim

16

Deireadh Fómhair 2018

0

Professional debate on biosimilar medicines in the Valencian Community

October 16 2018 biosim Biosim

13

Sep 2018

0

Biosimilar medicines in the EU

13 September 2018 Other entities Biosim

05

July 2018

0

The future of health: the advances of Biosimilars

Jul 05 2018 Other entities Biosim

29

Meitheamh 2018

0

The future of biosimilars

29 June 2018 Other entities Biosim

16

Apr 2018

0

Biosimilar medicines under debate: the crossroads of the scientific, the pharmacological, the legal and the ethical

Apr 16 2018 Other entities Biosim

11

December 2017

0

Drug experts propose boosting biosimilars

11 2017 December Other entities Biosim

16

Deireadh Fómhair 2017

0

Critical points in the production of biosimilars

October 16 2017 Other entities Biosim

26

Apr 2017

0

Biosimilar medicines, an opportunity for the health system

Apr 26 2017 Other entities Biosim

03

February 2017

0

Clinicians, pharmacists, politicians, economists and managers agree to promote the biosimilar

Feb 03 2017 Other entities Biosim

16

December 2016

0

Sandoz, 10 years of biosimilars

16 2016 December Other entities Biosim

12

December 2016

0

Múzquiz: "The regulatory change for the biosimilar is inalienable"

12 2016 December Other entities Biosim

11

February 2016

0

The global challenges for new cancer therapies

Feb 11 2016 Other entities Biosim

10

February 2016

0

What is a biosimilar? Biosimilars explained by a doctor and a pharmacist

Feb 10 2016 Other entities Biosim

21

November 2015

0

Medical Writing interview with Joaquín Rodrigo, president of Biosim

November 21 2015 biosim Biosim

13

November 2015

0

WEBINAR: Biologics & Biosimilars

November 13 2015 Other entities Biosim

06

November 2015

0

BioSim Presentation

November 06 2015 biosim Biosim

19

May 2015

0

The evolution of biotechnology: the appearance of biosimilars

19 May 2015 Other entities Biosim

31

Márta 2015

0

What is a biosimilar medicine?

March 31 2015 Other entities Biosim

29

Meitheamh 2013

0

Biosimilar trials explained

29 June 2013 Other entities Biosim

08

February 2013

0

Biosimilar Medicines: Present and Future. Europe vs. Spain

Feb 08 2013 Other entities Biosim

    BioSim Newsletter

    Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

    SUBSCRIBE